Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Sleep Apnea Syndromes: HELP
David A. Calhoun
Based on 20 articles published since 2008
||||
Expertise Level
The expertise of David A. Calhoun ranks in the
  • Top 0.15%
  • ... of 40,927 published authors worldwide on Sleep Apnea Syndromes
  • ... from 2008 through 2018
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Calhoun, David A   ·   Calhoun, D A   ·   Calhoun, D   ·   Calhoun, David
Work Locations
Details
Most likely:    University of Alabama Birmingham   Contact    
2017
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: · Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28109722
  • Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland, Australia. · Experimental Medicine CV/Hem, Clinical Sciences, Global Drug Discovery, Bayer Pharma AG, Wuppertal, Germany. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine and Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28382959
2016
  • Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA. · Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. · Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee, USA. · Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA. · Department of Cardiovascular Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Division of Nephrology and Hypertension, University of California Irvine Medical Center, Irvine, California, USA. · Pubmed 27427469
2015
  • Sleep Laboratory, Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. · Scientific Directory, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. · Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25761667
2013
  • Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil. · Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL. · Dante Pazzanese Institute of Cardiology, São Paulo, Brazil. · Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. · Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL; Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: · Pubmed 23288434
  • Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil; Sleep/Wake Disorders Center, The University of Alabama at Birmingham, Birmingham, AL. · Division of Pulmonary, Allergy and Critical Care Medicine, and Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: · Pubmed 23918137
2010
  • Vascular Biology and Hypertension Program, Sleep/Wake Disorders Center, University of Alabama at Birmingham, 430 BMR2, 1530 3rd Avenue South, Birmingham, AL 35294-2180, USA. · Pubmed 20424946
2013
  • University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Birmingham, AL 35294-2041 , USA. · Pubmed 23836977
2012
  • Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 22521297
  • Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL 35294-2041, USA. · Pubmed 22314116
  • Vascular Biology and Hypertension Program, Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35294,USA. · Pubmed 21654850
2010
  • Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham, AL, USA. · Pubmed 20726285
2009
  • Vascular Biology and Hypertension Program, University of Alabama, Birminham, CH19, Room 115, 1530 3rd Avenue South, Birmingham, AL 35294-2041, USA. · Pubmed 19942848
  • Vascular Biology and Hypertension Program, University of Alabama at Birmingham, 115 Community Health Services Building, 933 19th Street South, Birmingham, AL 35294, USA. · Pubmed 19863864
  • Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama 35294-2041, USA. · Pubmed 19395953
Possible:    Kaiser Los Angeles      
2011
  • Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA. · Pubmed 21720263
Possible:    Ochsner Medical Institutions   Contact    
2010
  • Division of Cardiovascular Diseases, Ochsner Clinic Foundation, New Orleans, LA, USA. · Pubmed 20016520
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by David A. Calhoun about Sleep Apnea Syndromes:

  • Sleep, insomnia, and hypertension: current findings and future directions. 2017
  • Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea. 2017
  • Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. 2016
  • Obstructive sleep apnea, hypertension and cardiovascular diseases. 2015
  • Aldosterone receptor antagonists: current perspectives and therapies. 2013
  • Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. 2013
  • Response. 2013
  • Resistant hypertension and aldosterone: an update. 2012
  • Recent advancements in the treatment of resistant hypertension. 2012
  • Resistant hypertension, obstructive sleep apnoea and aldosterone. 2012
Show List of Full Article Records
Google Searches

Learn more about David A. Calhoun using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Alabama Birmingham
Kaiser Los Angeles
Ochsner Medical Institutions
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Alabama Birmingham
2017
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: · Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28109722
  • Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland, Australia. · Experimental Medicine CV/Hem, Clinical Sciences, Global Drug Discovery, Bayer Pharma AG, Wuppertal, Germany. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine and Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28382959
2016
  • Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA. · Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. · Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee, USA. · Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA. · Department of Cardiovascular Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Division of Nephrology and Hypertension, University of California Irvine Medical Center, Irvine, California, USA. · Pubmed 27427469
2015
  • Sleep Laboratory, Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. · Scientific Directory, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil. · Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25761667
2013
  • Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil. · Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL. · Dante Pazzanese Institute of Cardiology, São Paulo, Brazil. · Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. · Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. · Sleep/Wake Disorders Center, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL; Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: · Pubmed 23288434
  • Endocrine Hypertension Research Centre and Clinical Centre of Research Excellence in Cardiovascular Disease and Metabolic Disorders, The School of Medicine, The University of Queensland, Princess Alexandra and Greenslopes Private Hospitals, Brisbane, QLD, Australia; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil; Sleep/Wake Disorders Center, The University of Alabama at Birmingham, Birmingham, AL. · Division of Pulmonary, Allergy and Critical Care Medicine, and Vascular Biology and Hypertension Program, The University of Alabama at Birmingham, Birmingham, AL. Electronic address: · Pubmed 23918137
2010
  • Vascular Biology and Hypertension Program, Sleep/Wake Disorders Center, University of Alabama at Birmingham, 430 BMR2, 1530 3rd Avenue South, Birmingham, AL 35294-2180, USA. · Pubmed 20424946
2013
  • University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Birmingham, AL 35294-2041 , USA. · Pubmed 23836977
2012
  • Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 22521297
  • Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL 35294-2041, USA. · Pubmed 22314116
  • Vascular Biology and Hypertension Program, Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35294,USA. · Pubmed 21654850
2010
  • Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham, AL, USA. · Pubmed 20726285
2009
  • Vascular Biology and Hypertension Program, University of Alabama, Birminham, CH19, Room 115, 1530 3rd Avenue South, Birmingham, AL 35294-2041, USA. · Pubmed 19942848
  • Vascular Biology and Hypertension Program, University of Alabama at Birmingham, 115 Community Health Services Building, 933 19th Street South, Birmingham, AL 35294, USA. · Pubmed 19863864
  • Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama 35294-2041, USA. · Pubmed 19395953
Kaiser Los Angeles
2011
  • Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA. · Pubmed 21720263
Ochsner Medical Institutions
2010
  • Division of Cardiovascular Diseases, Ochsner Clinic Foundation, New Orleans, LA, USA. · Pubmed 20016520
Miscellaneous institutions in Sao Paulo
2009
  • Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, SP, Brazil. · Pubmed 19249443
Yearly article counts 02110331342
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.